Hannah Valantine - 12 Jun 2026 Form 4 Insider Report for CareDx, Inc. (CDNA)

Reporting relationship: Director
Issuer ticker: CDNA
Reported as of: 12 Jun 2026
Net transaction value: -$279,728
SEC form: 4
Accepted by SEC: 16 Jun 2026, 17:51:28 UTC
Prior SEC filing: 04 Jun 2026
Next SEC filing: 24 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Jeffrey Adam Novack, Attorney-in-Fact

Key filing fact

Hannah Valantine filed Form 4 for CareDx, Inc. (CDNA) on 16 Jun 2026.

Key facts

This page summarizes Hannah Valantine's Form 4 filing for CareDx, Inc. (CDNA).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 16 Jun 2026, 17:51.

Change

Previous filing in this sequence was filed on 04 Jun 2026.
Current net transaction value: -$279,728.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001855608 Primary reporting owner

Valantine Hannah

Relationship: Director
Address: C/O CAREDX, INC., 8000 MARINA BOULEVARD, 4TH FLOOR, BRISBANE
Signature: /s/ Jeffrey Adam Novack, Attorney-in-Fact
Signature date: 16 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CDNA transaction

Common Stock

Award

Transaction value
Shares: +9,795
Change %: +25%
Price: $0.000000^*
Shares after: 48,789
Date: 12 Jun 2026
Ownership: Direct
Footnotes: F1

CDNA transaction

Common Stock

Sale

Transaction value: $279,728
Shares: -12,103
Change %: -25%
Price: $23.11
Shares after: 36,686
Date: 15 Jun 2026
Ownership: Direct
Footnotes: F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 3 footnotes

Footnote F1

The reported securities are represented by restricted stock units ("RSUs"), of which the RSUs vests 100% on the earlier of the one year anniversary of grant or the day immediately before the first Annual Meeting that occurs after the grant date., subject to the Reporting Person's continuous service on each applicable vesting date.

Footnote F2

The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2025.

Footnote F3

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.30 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.